RxDoctor Payments Data

Ricardo Rao, MD

Vascular Surgery · Saint Louis, MONPI 1427029362

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,745 of the $7,640 with a category attached, or 62.1%. 38 manufacturers reported payments, led by Idev Technologies, Inc. at 37.9% of the total. Reporting peaked in 2020 at $3,165 and has fallen 86.1% since, to $441 in 2025.

$7,640in general payments, 2019–2025

Across 128 payments — averaging $59.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Idev Technologies, Inc.$3K
  • Philips North America LLC$2K
  • Smith+Nephew$300
  • Johnson & Johnson$298
  • Silk Road Medical, Inc.$218
  • Bard Peripheral Vascular, Inc.$171
  • plus $2K from 32 others

What the payments were for

  • Food & beverage$4,74562%
  • Ownership interest$2,89638%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,640 in reported general payments places this provider in the 60th percentile of 92 vascular surgery providers in Missouri.

See all vascular surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$94,784
Medicare patients
300
Services billed
1,506

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pentoxifylline74$3,001
Gentamicin Sulfate23$1,410
Doxycycline Hyclate83$1,048
Clobetasol Propionate13$950
Cefadroxil42$556
Cilostazol16$233
Gabapentin17$217
ClopidogrelClopidogrel Bisulfate22$197
Clindamycin Hcl12$136
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$132
Atorvastatin Calcium13$124
Mupirocin23$122
Ciprofloxacin Hcl18$109
Triamcinolone Acetonide11$49

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →